Brookfield Corp’s Revance Therapeutics, Inc. RVNC Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q3 | – | Sell |
-58,727
| Closed | -$1.49M | – | 545 |
|
|
2023
Q2 | $1.49M | Buy |
+58,727
| New | +$1.49M | 0.01% | 425 |
|
|
2022
Q4 | – | Sell |
-124,347
| Closed | -$3.36M | – | 749 |
|
|
2022
Q3 | $3.36M | Sell |
124,347
-37,401
| -23% | -$1.01M | 0.01% | 342 |
|
|
2022
Q2 | $2.24M | Sell |
161,748
-35,375
| -18% | -$489K | 0.01% | 380 |
|
|
2022
Q1 | $3.84M | Buy |
+197,123
| New | +$3.84M | 0.01% | 287 |
|